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CONNECTIVE TISSUE ACTIVATION 
XV. Stimulation of Glycosaminoglycan and DNA Synthesis by a 
Polymorphonuclear Leukocyte Factor 
STEPHEN L. MYERS and C. WILLIAM CASTOR 
Human synovial fibroblasts in culture have been 
stimulated to augment hyaluronate synthesis and glu- 
cose utilization by connective tissue activating peptides 
(CTAP) extracted from human spleen, lymphocytes, 
platelets, granulocytes, and tumor cells. The platelet-de- 
rived mediator CTAP-I11 also stimulated DNA syn- 
thesis in synovial fibroblasts, but CTAP-I from lympho- 
cytes and spleen did not. The present study 
demonstrates the mitogenic potential of a granulocyte 
mediator (CTAP-PMN). Normal granulocytes were pre- 
pared with Ficoll-diatrizoate gradients, platelet con- 
tamination being estimated by phase microscopy and by 
radioimmunoassay for the platelet-specffic protein, /3- 
thromboglobulin. CTAP-PMN preparations derived 
from 4x10’ cells/ml stimulated culture 3H-thymidine in- 
corporation to 3.56 k 1.32 (SD) times control levels. Al- 
though exposure of preparations to thiols reduced their 
mitogenicity, CTAP-PMN was relatively heat-stable. 
SDS gel electrophoresis of active fractions suggested a 
molecular weight between 12,700 and 15,700 daltons. In 
double immunodiffusion, antisera to CTAP-I11 showed 
no reactivity with CTAP-PMN. CTAP-PMN or other 
granulocyte factors capable of stimulating fibroblast 
DNA synthesis may play a role in chronic proliferative 
synovitis or in other settings where exudative inflamma- 
tion is accompanied by connective tissue growth. 
Hyaluronic acid is the principle glycosaminogly- 
can (GAG) produced by synovial fibroblasts, both those 
lining the joint space and those cultivated in vitro. Sev- 
eral agents which stimulate or “activate” the synthesis 
of hyaluronate (HA) by cultured synovial fibroblasts 
have been identified and partially characterized chem- 
ically. These agents, denoted “Connective fissue Acti- 
vating Peptides” (CTAP), have been isolated from hu- 
man lymphocytes (CTAP-I), HE,., epithelial tumor 
cells (CTAP-11), and human platelets (CTAP-111) (1-3). 
Protease digestion destroys the biologic potency of these 
mediators, which range in molecular weight from 9,300 
to 14,600 daltons. The “activation” response to the 
CTAP mediators includes stimulation of culture glucose 
utilization and lactate production, GAG synthesis, and 
in some cases, stimulation of DNA synthesis. The 
mechanism by which these agents stimulate HA pro- 
duction involves increased fibroblast RNA and protein 
synthesis, and increases in prostaglandin E formation 
and intracellular cyclic AMP levels. CTAP-I11 is pres- 
ently the only one of these mediators known to stimu- 
late DNA synthesis in fibroblast cultures. In a rat fibro- 
blast line, increases in HA production have been 
produced by exogenous dibutyryl cAMP and cAMP 
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and by a calf serum factor with a molecular weight of 
approximately 100,ooo daltons (4,5). plasma somato- 
medins A and C, serum NSILA-S and P, and several 
platelet growth factors with molecular weights ranging 
stimulate either GAG synthesis Or both GAG synthesis 
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and cell division in cultured connective tissue cells (6). 
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The present study focuses on polymorphonuclear 
leukocytes, cells which predominate in effusions bathing 
the synovium in inflammatory arthropathies such as 
rheumatoid arthritis. In earlier studies, saline extracts 
prepared from granulocytes purified by adherence to 
glass beads stimulated HA synthesis, lactate production, 
and glucose utilization in synovial fibroblast cultures 
(7). Significant numbers of glass-adherent platelets and 
monocytes may have contributed to the stimulation ob- 
served in these experiments. The current study extends 
these observations on the role of the granulocyte in con- 
nective tissue activation. 
MATERIALS AND METHODS 
Granulocyte separation. Granulocytes were prepared 
on a discontinuous Ficoll-diatrizoate gradient similar to that 
discribed by Boyum (8). Healthy donors provided 60 ml sam- 
ples of venous blood which was anticoagulated with 0.27% 
ethylenediaminetetraacetic acid (EDTA). The samples were 
immediately diluted with 2.5 volumes of a calcium and mag- 
nesium-free buffered physiologic salt solution (Rabinowitz’s 
solution) (9). Solutions of 33.9% sodium diatrizoate (Win- 
throp, New York) and of 9% Ficoll400 (Pharmacia, Uppsala, 
Sweden) were mixed in a 1:2.3 ratio by volume to a specific 
gravity of 1.083 +- 0.001 at 16°C. Thirty-five milliliters of this 
gradient solution were placed in a 60 x 145 mm centrifuge 
bottle and overlayered with 100-120 ml of dilute blood. After 
centrifugation (400g, room temperature, 30 minutes), the 
platelet-mononuclear cell layer was carefully removed and 
again centrifuged (17,30Og, 4”C, 10 minutes) to obtain a cell- 
free supernate. The erythrocytes and granulocytes were re- 
moved from the separation bottle and resuspended in this su- 
pernatant solution. Dextran (Sigma, St. Louis) was added to a 
final concentration of 0.8%, and the erythrocytes were allowed 
to sediment at 4°C. Granulocytes were harvested from the re- 
sulting supernatant fluid by low-speed centrifugation (150g, 
room temperature, 10 minutes) and suspended in 0.87% 
NH,Cl to lyse remaining erythrocytes. The cells were then 
washed, counted, and frozen at -70°C. Granulocyte yield 
ranged between 55% and 85% of the whole blood population, 
or about 5 X lo7 granulocytes/60 ml blood. Differential 
counts distinguishing mononuclear cells and granulocytes 
were performed on cell suspensions stained with crystal violet. 
Enumeration of platelets and leukocytes was carried out with 
hemocytometers using phase contrast illumination. 
Fibroblast culture. Normal synovia obtained at ar- 
throtomy or amputation were divided into explants from 
which synovial fibroblast strains were cultivated in mono- 
layer, as previously reported (10). Routine culture medium 
consisted of 80% medium 1066, 10% fetal calf serum, and 10% 
heat-inactivated pooled human serum with supplementary L- 
glutamine, penicillin G, streptomycin, and 0.02M Hepes buf- 
fer, pH 7.4. 
Assay for fibroblast “activation.” The standard 
bioassay for fibroblast “activation” in the presence of the 
CTAP mediators has been previously described (1 1). Gran- 
ulocyte extracts and other samples in these assays were dia- 
lyzed overnight at 4°C against 0.05M phosphate-buffered sa- 
line (PBS), pH 7.0, and precipitates which formed during 
dialysis were removed by centrifugation. Samples were steri- 
lized by Millipore filtration and stored at 0°C. Sufficient T-15 
culture flasks were each planted with lo6 synovial fibroblasts 
to allow triplicate control and duplicate experimental assay 
flasks. After cell attachment was complete (4-6 hours), a 
serum-free assay medium (2 ml Eagle’s basal medium with 
0.02M Hepes buffer, pH 7.4, L-glutamine, penicillin G, and 
streptomycin) was introduced. Control flasks were charged 
with 0.3 ml PBS, and samples were added in a similar volume. 
After 40 hours of incubation at 35-37”C, the medium was re- 
moved. Hyaluronic acid in the medium from each flask was 
isolated by cetylpyridinium chloride precipitation (1 1) and 
quantitated by determining uronic acid with a modified car- 
bazole method (12). Cell sheet protein was measured by the 
method of Oyama and Eagle (13). 
Measurement of mitogenic activity. The rate of DNA 
synthesis in cultured fibroblasts was evaluated in cells in- 
cubated with ’H-methylthymidine as described recently (2,3). 
Aliquots of 104 cells were placed in 6.4 mm microtiter wells in 
an assay medium containing 97% Eagle’s standard medium 
(ESM), 3% fetal calf serum, 0.02M Hepes, and L-glutamine. 
After a 24-hour incubation at 37”C, fresh medium (200 pl) 
and samples (5-7.5 pCi, 15pl) were added. ’H-methyl- 
thymidine (1.5 pl) was added and incubation at 37°C was re- 
sumed for an additional 24 hours. The medium was then dis- 
carded, and the cell sheets were washed twice with PBS at pH 
7.0. After single washes with 5% trichloroacetic acid and abso- 
lute methanol, the cell sheets were dried and extracted with 
0.3N NaOH (50 pl). Extracts were spotted on glass fiber filter 
paper (Whatman grade 934 AH, H. Reeve Angel Inc., Clifton, 
New Jersey) and counted in a Beckman Series 7,000 liquid 
scintillation counter. 
Miscellaneous methods. SDS polyacrylamide gel elec- 
trophoresis was performed in 15% slab gels. Molecular weight 
standards as well as other enzymes were obtained com- 
mercially (Sigma, St. Louis). Neutral protease activity was de- 
tected by measuring color released from a substrate of blue 
azure dye bound to hide powder during an 18-hour in- 
cubation at pH 7.0, 37°C (14). Trypsin (2 X crystallized) was 
used as a standard. CTAP-I11 preparations were prepared as 
previously described (2,3). 
Beta-thromboglobulin assay. Radioimmunoassay for 
beta-thromboglobulm (P-TG) (Amersham, Chicago) was per- 
formed with 50% of the reagent volumes per assay tube rec- 
ommended by the supplier. This did not affect the sensitivity 
or reproducibility of the standard curve in the range between 
10 and 20 ng P-TG/ml. Theophylline (0.18 mg/ml) and 3.3% 
EDTA were added to blood samples from which normal 
platelets were collected for P-TG assay to minimize platelet 
release phenomena, and all samples were measured in dupli- 
cate. 
RESULTS 
Identification of granulocyte CTAP activity. The 
potential of granulocytes to stimulate fibroblasts (“acti- 
vation”) was compared with that of platelets and mono- 
nuclear cells which would serve as sources of previously 
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8.52 f 0.59 
18.46 f 1.06 
52.97 f 0.47 
21.00 +. 0.13 
46.04 +. 0.27 
- - 
1.2 to.01 
1 . 1  t O . O O 1  
1.4 t0.002 
1 . 1  <0.001 
* Pellets of purified granulocytes or mononuclear cells and platelets 
from Ficoll-diatrizoate gradients were subjected to three rapid freeze- 
thaw cycles in assay medium, and aliquots of the suspensions were as- 
sayed. 
identified CTAP factors. Crude cell extracts of the gran- 
ulocyte and the mononuclear-platelet layers of two Fi- 
coll-diatrizoate gradients were prepared by freeze-thaw- 
ing the cells in serum-free fibroblast culture medium 
(Table 1). Seventy-eight percent of the whole blood 
granulocytes was recovered mononuclear cell recovery 
was 50% and platelet recovery was greater than 90%. 
The extracts were added to fibroblast cultures, 
and culture hyaluronate production was measured as an 
indicator of the activation phenomenon. The gran- 
ulocyte extracts stimulated significant increases in cul- 
ture HA (P < 0.01, t = 11.5). Mononuclear and platelet 
extracts were much more potent stimulants of HA pro- 
duction, which suggested that most of the CTAP activ- 
ity in whole blood resides in these cells. These data also 
indicated that the contamination of granulocyte prepa- 
rations by relatively few platelets or mononuclear cells 
might lead to falsely elevated estimates of granulocyte 
CTAP activity. 
In early studies, evaluation of platelet and mono- 
nuclear cell contamination in granulocyte preparations 
were routinely obtained with 1.7 k 1.0% (SD) mono- 
nuclear cell contamination. Platelet contamination was 
difficult to evaluate with this technique because of 
platelet and leukocyte clumping. Platelet counts per- 
formed under phase contrast optics were more useful. 
Platelet contamination as estimated by this technique 
ranged from 5.3 to 51 platelets per 100 granulocytes. 
Beta-thromboglobulin was recently described by 
Pepper and Moore as a platelet-specific protein (1 5) .  In 
synovial fibroblast cultures it has virtually no capacity 
to stimulate GAG or DNA synthesis (3). The amino 
acid sequences of ,8-TG and CTAP-I11 have recently 
been reported (16,17). CTAP-I11 contains four addi- 
tional amino acids at its N-terminus but is otherwise 
identical to p-TG. Several antisera prepared in rabbits 
and in mice with highly purified CTAP-I11 cross- 
reacted with samples of P-TG, suggesting that these 
additional residues do not contribute to the molecules' 
antigenicity (3). A commercially available radioimmu- 
noassay (Amersham, Chicago) developed for p-TG, but 
cross-reacting with and also measuring CTAP-111, was 
used to detect low levels of platelet contamination (1 8). 
Platelets were collected from healthy donors in 
the presence of EDTA and theophylline and with rapid 
cooling to prevent loss of platelet contents. The p-TG 
antigen C(3-TGAg) content of extracts prepared by freeze- 
thawing platelets in the presence of 0.01% Triton X-100 
was measured by radioimmunoassay. These extracts 
contained 12.5 f 4.0 picograms p-TGAg per lo3 platelets 
(n = 11). The addition of human thrombin to platelets 
released 87% of their p-TGAg during a 10-minute in- 
cubation at 21°C. 
Aliquots of granulocytes purified on isopycnic 
Ficoll-diatrizoate gradients were similarly extracted and 
assayed for p-TGAg content. Between 0.04 and 0.40 
picograms ,8-TGAe were present per 100 granulocytes, 
with a mean of 0.19 f 11 pg/lOO WBC (n = 12). This 
provided an independent measure of platelet con- 
tamination of granulocyte preparations. An average of 
15 platelets per 100 granulocytes remained (based on p- 
TGAg calculations) in carefully prepared granulocyte 
pellets. Incubation of aliquots of freshly separated gran- 
ulocytes with thrombin produced a 77% reduction in 
their p-TGAg content as platelet release occurred. This 
suggested that although small amounts of p-TGAg might 
be adsorbed to cell pellets, granulocytes do not contain 
P-TGAg or CTAP-111. 
To demonstrate that CTAP factors derived from 
contaminant lymphocytes and platelets were present in 
quantities too small to stimulate fibroblasts, mono- 
nuclear cells (90% lymphocytes) collected from separa- 
tion gradients (96% purity) were treated with thrombin 
and washed to free them of platelet contamination. 
Platelets were collected from fresh plasma with only 
rare contaminant leukocytes. Both platelets and mono- 
nuclear cells were extracted with 80% ethanol, 20% 
1.25N HC1 (acid-ethanol) at 4°C. Extracts of gradient 
purified granulocytes were prepared in the same man- 
ner. After dialysis against phosphate buffered saline, the 
volumes of the platelet and mononuclear cell extracts 
were adjusted so that they were assayed at concentra- 
tions proportionate to their numbers as contaminants in 
separated granulocyte preparations. The P-thrombo- 
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S A L I N E  PLATELETS MONONUC. PMNS CTAP 111 
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I 
0 
Figure 1. Purified granulocytes or platelets and mononuclear cells in quantities reflecting their presence as con- 
taminants of the granulocytes were extracted with acid-ethanol. Partially purified samples of platelet-derived 
CTAP-111 were used as positive controls. P-Thromboglobulin antigen @-TG) concentrations were determined 
per ml of extract. 
globulin antigen content of the preparations at assay di- 
lution confirmed the accuracy of this adjustment with 
platelets (Figure 1). Neither the dilute platelet nor the 
mononuclear cell extract stimulated HA synthesis. The 
crude granulocyte extract produced substantial in- 
creases in both HA production and DNA synthesis. 
Furthermore, fibroblast DNA synthesis was not signifi- 
cantly increased by the platelet and mononuclear cell 
extracts at these low concentrations. 
These observations suggested that both fibro- 
blast HA and DNA synthesis were stimulated by a 
granulocyte-derived factor. Several extracts prepared 
Table 2. CTAP-PMN activity of normal granulocytes 
from granulocytes obtained from 5 healthy adults and 
tested with one strain of synovial fibroblast produced 
similar levels of stimulation of HA synthesis (Table 2). 
These extracts also stimulated substantial increases in 
’H-methylthymidine incorporation. The potency of a 
particular extract in stimulating HA synthesis was not 
proportional to its mitogenic activity in this experiment, 
and it seemed possible that different granulocyte factors 
might be biologically active in each assay system. 
Extraction and fractionation of CTAP-PMN. 
Crude granulocyte extracts capable of “activating” sy- 
novial fibroblasts could be produced by freeze-thawing 
PMN x 10-7 P-TGA~ 
extracted, ng/ml 
Sample* ml extract extractt 
A 4.0 8.5 
B 2.2 10.5 
C 4.0 7.0 
D 4.0 40.0 

























* Crude acid-ethanol extracts of cells from five healthy adults were assayed using one strain of syno- 
t Platelet contamination was measured by using a radioimmunoassay for the P-thromboglobulin anti- 
$ exp/con = experimental/control. 
8 Neutral protease activity was determined using trypsin as a standard. NT = not tested. 
vial fibroblasts. 
gen (p-TGAg). 
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Fraction synthesis synthesis 
protein, p-TGAg exp/con exp/con 
ag/mlt ng/ml$ f SDg f SDg 
Crude 2,160 85 12.65 f 0.23 4.81 f 0.28 
RT 850 47 13.45 f 0.87 4.16 f 0.20 
pH 5.2 727 207 11.19 f 1.61 3.48 f 0.29 
pH 7.2 594 43 3.73 f 0.86 2.09 f 0.26 
NaOH 806 - 1.43 f 0.52 1.63 f 0.41 
* A crude granulocyte extract was applied to SP-Sephadex in 
0.05M citrate buffer, pH 3.2, and the unbound protein was collected 
(RT). Elution followed with 0.05M citrate + 0.5M NaCl, pH 5.2; 
0.05M citrate + 1.OM NaCl, pH 7.2; and 0.1N NaOH. 
t Fractions were lyophilized and dialyzed versus buffered saline 
prior to assay. + P-thromboglobulin antigen @-TGAg) was measured by radioim- 
munoassay. 
0 exp/con = experiment/control. 
in CMRL- 1066 culture medium or a balanced salt solu- 
tion (Hank's), but were of generally low potency and 
very labile. Extracts prepared in acidic vehicles @H less 
than 3) such as 0.02M acetic acid or 20% 1.25M HC1 + 
80% ethanol (acid ethanol) were more active. Most of 
the hyaluronate-stimulating activity of the acid ethanol 
extracts was precipitated by addition of 3 volumes of 
cold (4°C) acetone, and could be redissolved in 0.1- 
1.OM citric or acetic acid. The initial acid-ethanol ex- 
traction solubilized about 60% of the protein in gran- 
ulocyte pellets. Approximately 15% of the extracted pro- 
tein was precipitated when these extracts were dialyzed 
to pH 7.4 prior to bioassay. Further precipitate forma- 
tion and loss of biologic potency were often observed in 
crude preparations stored at -40°C. 
Acid ethanol granulocyte extracts were partially 
purified by cation exchange chromatography on SP- 
Sephadex. A crude extract was applied to the cation ex- 
change column in 0.05M citrate buffer, pH 3.2. Elution 
with citrate buffer @H 5.2 containing 0.5M NaC1) fol- 
lowed by lyophilization and dialysis versus buffered sa- 
line recovered a CTAP-PMN fraction containing about 
30% of the bound protein (Table 3). This fraction effec- 
tively stimulated HA and DNA synthesis in bioassay. 
The P-TGAg concentration of this fraction was enriched 
in comparison to crude extracts, suggesting copurifica- 
tion of CTAP-PMN, P-TG, and CTAP-111. On SDS 
slab gel electrophoresis in 15% acrylamide gels, the un- 
bound fraction was similar in appearance to the crude 
extract (Figure 2). The pH 5.2 fraction contained three 
distinct bands corresponding to molecular weights be- 
tween 12,700 and 15,700 daltons. It should be noted that 
CTAP-I11 (MW 9,300 daltons) and P-thromboglobulin 
(MW 8,85 1 daltons) could not be resolved on these gels. 
Further evidence regarding the molecular weight of 
CTAP-PMN was obtained by gel filtration chroma- 
tography on Sephadex G-50 or G-75 in 0.2-1.OM acetic 
or citric acid. Fractions which stimulated HA and DNA 
synthesis were eluted just before and with the elution 
volume of lysozyme (MW 14,400 daltons). 
Characteristics of CTAP-PMN. The partially 
purified CTAP-PMN preparation eluted as the pH 5.2 
SP-Sephadex fraction was used in further character- 
ization studies. The molecular weight of the active 
factor(s) was estimated to be 14,100 daltons. This prepa- 
ration produced half-maximal stimulation of 3H-thymi- 
dine incorporation at approximately the same concen- 
tration (1.0 nM/ml) as CTAP-I11 (Figure 2). This 
represented a conservative estimate of the biologic po- 
tency of CTAP-PMN, since it assumed that all peptides 
4.0 
2.01 
CTAP- PMN, nmoles/ml 
Figure 2. Stimulation of 'H-thymidine incorporation in one strain of 
human synovial fibroblasts by partially purified CTAP-PMN (pH 5.2 
fraction). 
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Figure 3. Partially purified CTAP-PMN (PH 5.2 fraction, 3.4 pg) was 
incubated (37”C, 18 hours) with saline (control), pronase 0.25 pg, soy- 
bean trypsin inhibitor (STI) (2.5 pg), trypsin 0.25 pg, or trypsin + STI 
0.25 + 2.5 pg. The mixtures were then assayed. 
present were biologically active. This fraction was used 
to investigate the heat and thiol reagent stability of 
CTAP-PMN. A 28% loss in mitogenic activity was ob- 
served after overnight incubation at 37”C, possibly as a 
result of autolysis. Forty-four percent of the initial ac- 
tivity remained after exposure to 100°C for 10 minutes 
followed by cooling at room temperature. A 2-hour ex- 
posure to 100°C rendered CTAP-PMN inactive. It did 
not stimulate ’H-thymidine incorporation after it had 
been incubated with 0.001M dithioerythritol (DTE) at 
37°C for 18 hours. 
Like the other CTAP factors, CTAP-PMN was 
inactivated by protease digestion. Trypsin, pronase, and 
soybean trypsin inhibitors were not mitogenic when 
added to cultures alone. Incubation of the granulocyte 
factor with pronase prior to adding the mixture to fi- 
broblast cultures abolished the mitogenic potential of 
the factor (Figure 2). Trypsin was less destructive than 
pronase at 50 pg/ml concentrations. When proteolytic 
digestion of CTAP-PMN by trypsin was prevented by 
including an excess of soybean trypsin inhibitor in the 
incubation mixture, CTAP-PMN activity was pre- 
served. 
Crude CTAP-PMN preparations contained pro- 
tease activity against a hide powder substrate at pH 7.0 
equivalent to between 11 and 35 ng of trypsin/ml. The 
protease activity of these extracts did not appear to cor- 
relate with their effectiveness as stimulants of HA or 
DNA synthesis (Table 2). Furthermore, crude CTAP- 
PMN effectively stimulated fibroblast DNA synthesis in 
the presence of soybean trypsin inhibitor at a concentra- 
tion (500 pg/ml) which blocked hide powder digestion. 
Partially purified preparations of CTAP-PMN 
were tested in Ouchterlony plates with antisera to 
CTAP-I11 raised in rabbits and mice. No precipitin lines 
were formed with CTAP-PMN preparations. 
DISCUSSION 
Identification of a specific granulocyte CTAP 
factor required highly purified granulocytes. Using iso- 
tonic density gradients, Loos and Roos determined that 
granulocytes have a buoyant density of 1.082 gm/ml 
(19). An upper limit for the buoyant density of normal 
platelets was determined by Corash et a1 to be 1.084 
gm/ml, with only 14% of the platelet population being 
more dense than 1.07 1 gm/ml(20). Accordingly, Ficoll- 
diatrizoate gradient mixtures designed to recover lym- 
phocytes at a specific gravity of 1.077 gm/ml allow sig- 
nificant numbers of platelets to pass through the gradi- 
ent interface and mix with the more dense granulocytes 
and erythrocytes. 
By using Ficoll-diatrizoate gradients similar to 
those devised by Boyum, but made nearly isopyric for 
granulocytes (1.083 gm/ml), we retained 99.2% of the 
platelets in whole blood above the gradient interface 
and recovered purified granulocytes below this interface 
A radioimmunoassay for the platelet P-throm- 
boglobulin antigen was used to measure low levels of 
platelet contamination in separated granulocytes. Ap- 
proximately 400 platelets/mm’ could be detected with 
this assay, corresponding to 0.2% of the normal blood 
platelet count. Normal platelets were found to contain 
12.5 f 4.0 pg p-TGAg per lo’ platelets. By using a mean 
normal platelet density of 1.058 gm/ml(l9) and a mean 
platelet volume of 5.17 pm’ (20), it was calculated that 
2.55 f 0.82 mg /3-TGAg was present in a gram of fresh 
platelets. Pepper and Moore have reported a similar 
value of 1.24 mg P-thromboglobulin per gram of plate- 
lets (1 5). Their somewhat lower value might reflect the 
facility with which P-TG is released from platelets in 
vitro. 
We have applied the term “CTAP-PMN” to the 
granulocyte-derived factor which stimulates both DNA 
and HA synthesis in synovial fibroblasts. It was ex- 
tracted from granulocytes under essentially the same 
conditions used in preparing CTAP-I11 from platelets, 
i.e., low pH and low ionic strength. 
Since measurements of the P-thromboglobulin 
antigen by radiommunoassay did not discriminate be- 
tween mitogenic CTAP-I11 and inactive P-thrombo- 
globulin, the CTAP-I11 content of CTAP-PMN prepa- 
(8). 
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F i k e  4. Slab gel electrophoresis using SDS CTAP-PMN activity resides in a protein(s) with a molecular weight between 
12,000-16,OOO daltons. 
rations was estimated. The dose response curve of puri- 
fied CTAP-I11 suggests that greater than 500 ng/ml of 
that factor is required to stimulate two-fold or greater 
increases in culture ’H-thymidine incorporation (3). No 
more than 207 ng/ml P-TGA8 were present in any of the 
CTAP-PMN preparations assayed, evidence that the 
observed stimulation of DNA synthesis by these ex- 
tracts was not attributable to CTAP-I11 contamination. 
In crude CTAP-PMN extracts, small quantities 
of other platelet growth factors may have been present. 
However, the few platelets contaminating these prepa- 
rations did not stimulate increases in DNA synthesis 
when they were assayed alone (Figure 1). The possi- 
bility that CTAP-PMN activity may be additive to or 
potentiate platelet growth factor activity has not yet 
been investigated. 
Partially purified CTAP-PMN contained at least 
three peptides with molecular weights ranging between 
12,700 and 15,700 daltons. Current evidence suggests 
that one peptide stimulates both hyaluronate and DNA 
synthesis. It was not possible to diminish one biologic 
activity with heat, thiol reagents, or by proteolytic di- 
gestion without concomitant loss of the other. Like 
platelet-derived growth factor(s), CTAP-PMN was rela- 
tively resistant to heating at 100°C. Most of the cur- 
rently identified mitogenic factors active on connective 
tissue contain intramolecular disulfide bonds which are 
required for their biologic activity (6). CTAP-PMN was 
inactivated by incubation with dithioerythritol, suggest- 
ing that it contains at least one disulfide bond. Like the 
previously described CTAP factors, its biologic activity 
was protease-labile. Important antigenic differences ap- 
pear to exist between CTAP-I11 and CTAP-PMN, since 
precipitin lines failed to form between anti-CTAP-I11 
antibody and CTAP-PMN preparations in Ouchterlony 
analysis. 
The hypothesis that weak neutral protease activ- 
ity present in preparations of CTAP-PMN was respon- 
sible for the observed stimulation of ’H-thymidine in- 
corporation was investigated by using soybean trypsin 
inhibitor. Although the activity of CTAP-PMN was not 
diminished by the presence of this protease inhibitor, 
the role that granulocyte proteases may play in synovial 
fibroblast activation and growth has not been deter- 
mined. 
In 1921, Carrel applied the term “trephone” to 
the growth-promoting substances presumably present in 
inflammatory cells (22). Investigators of wound healing 
have generally related the extent of fibrosis in healed 
experimental wounds to the intensity of inflammatory 
response (23). The studies of Simpson and Ross sug- 
gested that neutrophils were not required for wound 
healing in guinea pigs treated with antineutrophil 
serum, since neutropenic and control wounds contained 
histologically similar numbers of fibroblasts and colla- 
gen fibers (24). On the other hand, extracts of guinea 
pig leukocyte lysosomes were reported to simulate pro- 
line incorporation in fibroblast cultures and to increase 
the mechanical resistance of healing skin wounds (25). 
The in vivo importance of CTAP-PMN as a 
CONNECTIVE TISSUE ACTIVATION 563 
mitogenic factor in wounds, in the joint space, or at 
other sites of acute and chronic inflammation remains 
unclear. The liberation of chemotactic factors at sites of 
tissue injury quickly attracts large numbers of gran- 
ulocytes from the vascular space. Platelets appear to be 
more potent than the granulocytes as a source of factors 
which promote fibroblast “activation” and DNA syn- 
thesis in vitro. However, there is Little evidence to sug- 
gest that platelet release continues to occur at sites of in- 
jury after hemostasis has been established. Granulocyte 
and monocyte-derived factors might be expected to play 
major roles in modulating the later cellular responses to 
injury. The generally sequential recruitment of plate- 
lets, granulocytes, macrophages, and lymphocytes in the 
response to tissue injury might permit CTAP factors 
from each cell type to participate in the local control of 
fibroblast synthetic activity. 
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